Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. 1993

M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
Department of Medicine, CHU Sart Tilman, University of Liège, Belgium.

To study the mechanisms of glucose intolerance and hyperinsulinism in liver cirrhosis, we compared the plasma glucose, insulin, and C-peptide levels during a frequently sampled i.v. glucose tolerance test (0.3 g glucose/kg BW) in nine compensated cirrhotic patients and nine healthy volunteers well matched for age, sex, and body weight. The insulin secretion rate was derived by the deconvolution of plasma C-peptide levels, insulin sensitivity was calculated using Bergman's minimal model method, and insulin clearance was estimated by dividing the 0-180 min area under the curve of insulin secretion rate by that of peripheral plasma insulin levels. The cirrhotic patients were characterized during the frequently sampled i.v. glucose tolerance test by a 60% greater insulin secretion rate (P < 0.05), a markedly reduced insulin sensitivity index (SI; 2.82 +/- 0.75 vs. 5.86 +/- 0.68 x 10(-4) min/mU.L; P < 0.01) and a 40% reduced insulin clearance (725 +/- 169 vs. 1165 +/- 99 mL/min.m-2; P < 0.05). The reduction of insulin clearance was significantly correlated with the amplitude of the portosystemic shunt, measured using an isotopic method (r = 0.75; P < 0.02). In conclusion, cirrhosis is characterized by an important peripheral hyperinsulinism, resulting from both a higher insulin secretion rate and a reduced insulin hepatic clearance; the severe insulin resistance explains the glucose metabolism alterations.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
February 1996, The American journal of physiology,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
May 2009, Diabetes care,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
February 1993, Diabetologia,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
July 2006, Diabetes,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
May 1973, Endokrinologie,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
August 2007, Diabetes care,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
March 2019, Obesity (Silver Spring, Md.),
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
February 2008, The Journal of biological chemistry,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
January 2014, Diabetologia,
M R Letiexhe, and A J Scheen, and P L Gérard, and B H Bastens, and J Pirotte, and J Belaiche, and P J Lefèbvre
October 1997, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!